These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16462423)

  • 1. Mineral changes in osteoporosis: a review.
    Faibish D; Ott SM; Boskey AL
    Clin Orthop Relat Res; 2006 Feb; 443():28-38. PubMed ID: 16462423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.
    Tjhia CK; Odvina CV; Rao DS; Stover SM; Wang X; Fyhrie DP
    Bone; 2011 Dec; 49(6):1279-89. PubMed ID: 21958843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology.
    Lundy MW; Wergedal JE; Teubner E; Burnell J; Sherrard D; Baylink DJ
    Bone; 1989; 10(5):321-7. PubMed ID: 2605048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relating micromechanical properties and mineral densities in severely suppressed bone turnover patients, osteoporotic patients, and normal subjects.
    Tjhia CK; Stover SM; Rao DS; Odvina CV; Fyhrie DP
    Bone; 2012 Jul; 51(1):114-22. PubMed ID: 22561877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered distributions of bone tissue mineral and collagen properties in women with fragility fractures.
    Wang ZX; Lloyd AA; Burket JC; Gourion-Arsiquaud S; Donnelly E
    Bone; 2016 Mar; 84():237-244. PubMed ID: 26780445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women.
    Roschger P; Rinnerthaler S; Yates J; Rodan GA; Fratzl P; Klaushofer K
    Bone; 2001 Aug; 29(2):185-91. PubMed ID: 11502482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation.
    Boskey AL; DiCarlo E; Paschalis E; West P; Mendelsohn R
    Osteoporos Int; 2005 Dec; 16(12):2031-8. PubMed ID: 16088360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fourier transform-infrared microspectroscopy and microscopic imaging.
    Gourion-Arsiquaud S; West PA; Boskey AL
    Methods Mol Biol; 2008; 455():293-303. PubMed ID: 18463826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical study of bone mineral in biopsies of osteoporotic patients before and after long-term treatment with fluoride.
    Baud CA; Very JM; Courvoisier B
    Bone; 1988; 9(6):361-5. PubMed ID: 3248199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide.
    Tanaka S; Kuroda T; Sugimoto T; Nakamura T; Shiraki M
    Curr Med Res Opin; 2014 May; 30(5):931-6. PubMed ID: 24392946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae.
    Busse B; Hahn M; Soltau M; Zustin J; Püschel K; Duda GN; Amling M
    Bone; 2009 Dec; 45(6):1034-43. PubMed ID: 19679206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers.
    Bone HG; Downs RW; Tucci JR; Harris ST; Weinstein RS; Licata AA; McClung MR; Kimmel DB; Gertz BJ; Hale E; Polvino WJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):265-74. PubMed ID: 8989272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from steroid-induced osteoporosis.
    Pocock NA; Eisman JA; Dunstan CR; Evans RA; Thomas DH; Huq NL
    Ann Intern Med; 1987 Sep; 107(3):319-23. PubMed ID: 3619221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of mineral to bone structural behavior and tissue mechanical properties.
    Donnelly E; Chen DX; Boskey AL; Baker SP; van der Meulen MC
    Calcif Tissue Int; 2010 Nov; 87(5):450-60. PubMed ID: 20730582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorder.
    Costa AG; Bilezikian JP; Lewiecki EM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):324-9. PubMed ID: 26050118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone structure in rheumatoid arthritis].
    Ono K; Ohashi S; Tanaka S; Matsumoto T
    Clin Calcium; 2013 Jul; 23(7):983-91. PubMed ID: 23811586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD.
    Valkema R; Vismans FJ; Papapoulos SE; Pauwels EK; Bijvoet OL
    Bone Miner; 1989 Jan; 5(2):183-92. PubMed ID: 2920240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral alterations in senile osteoporosis.
    Mongiorgi R; Romagnoli R; Olmi R; Moroni A
    Biomaterials; 1983 Jul; 4(3):192-6. PubMed ID: 6615982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.